loadpatents
Patent applications and USPTO patent grants for KUNTZ; Kevin W..The latest application filed is for "combination therapy for treating cancer".
Patent | Date |
---|---|
Combination Therapy For Treating Cancer App 20220226336 - KEILHACK; Heike ;   et al. | 2022-07-21 |
Aryl-or Heteroaryl-substituted Benzene Compounds App 20210379076 - KUNTZ; Kevin W. ;   et al. | 2021-12-09 |
Method Of Treating Leukemia App 20210268012 - OLHAVA; Edward J. ;   et al. | 2021-09-02 |
Substituted Purine And 7-deazapurine Compounds App 20210252035 - OLHAVA; Edward J. ;   et al. | 2021-08-19 |
Aryl-or heteroaryl-substituted benzene compounds Grant 11,052,093 - Kuntz , et al. July 6, 2 | 2021-07-06 |
Method of treating leukemia Grant 10,881,680 - Olhava , et al. January 5, 2 | 2021-01-05 |
Inhibitors Of Human Ezh2, And Methods Of Use Thereof App 20200397812 - COPELAND; Robert A. ;   et al. | 2020-12-24 |
Substituted 6,5-fused Bicyclic Heteroaryl Compounds App 20200317643 - KUNTZ; Kevin W. ;   et al. | 2020-10-08 |
Aryl-or Heteroaryl-substituted Benzene Compounds App 20200155562 - KUNTZ; Kevin W. ;   et al. | 2020-05-21 |
Combination Therapy For Treating Cancer App 20200113911 - KEILHACK; Heike ;   et al. | 2020-04-16 |
Combination therapy for treating cancer Grant 10,463,671 - Keilhack , et al. No | 2019-11-05 |
Substituted 6,5-fused Bicyclic Heteroaryl Compounds App 20190300502 - KUNTZ; Kevin W. ;   et al. | 2019-10-03 |
Aryl-or heteroaryl-substituted benzene compounds Grant 10,420,775 - Kuntz , et al. Sept | 2019-09-24 |
Method Of Treating Leukemia App 20190216838 - OLHAVA; Edward J. ;   et al. | 2019-07-18 |
Aryl-or Heteroaryl-substituted Benzene Compounds App 20190192526 - KUNTZ; Kevin W. ;   et al. | 2019-06-27 |
1,4-pyridone bicycic heteroaryl compounds Grant 10,150,759 - Kuntz , et al. Dec | 2018-12-11 |
Aryl-or Heteroaryl-substituted Benzene Compounds App 20180318309 - KUNTZ; Kevin W. ;   et al. | 2018-11-08 |
Combination Therapy For Treating Cancer App 20180280402 - KEILHACK; Heike ;   et al. | 2018-10-04 |
Inhibitors Of Human Ezh2, And Methods Of Use Thereof App 20180271892 - COPELAND; Robert A. ;   et al. | 2018-09-27 |
Hydrochloride salt form for EZH2 inhibition Grant 10,040,782 - Kuntz , et al. August 7, 2 | 2018-08-07 |
Substituted 6,5-fused Bicyclic Heteroaryl Compounds App 20180208591 - CAMPBELL; John Emmerson ;   et al. | 2018-07-26 |
1,4-pyridone Bicyclic Heteroaryl Compounds App 20180134692 - KUNTZ; Kevin W. ;   et al. | 2018-05-17 |
Inhibitors of human EZH2, and methods of use thereof Grant 9,949,999 - Copeland , et al. April 24, 2 | 2018-04-24 |
Aryl-or heteroaryl-substituted benzene compounds Grant 9,855,275 - Kuntz , et al. January 2, 2 | 2018-01-02 |
Aryl-or Heteroaryl-substituted Benzene Compounds App 20170252349 - KUNTZ; Kevin W. ;   et al. | 2017-09-07 |
1,4-pyridone bicyclic heteroaryl compounds Grant 9,701,666 - Kuntz , et al. July 11, 2 | 2017-07-11 |
Method Of Treating Leukemia App 20170165288 - Olhava; Edward J. ;   et al. | 2017-06-15 |
Method of treating leukemia Grant 9,597,348 - Olhava , et al. March 21, 2 | 2017-03-21 |
Inhibitors of Human EZH2, and Methods of Use Thereof App 20170065628 - Copeland; Robert A. ;   et al. | 2017-03-09 |
Substituted Benzene Compounds App 20160332969 - Kuntz; Kevin W. ;   et al. | 2016-11-17 |
Combination Therapy For Treating Cancer App 20160303135 - Keilhack; Heike ;   et al. | 2016-10-20 |
Hydrochloride Salt Form For Ezh2 Inhibition App 20160237068 - KUNTZ; Kevin W. ;   et al. | 2016-08-18 |
Carbocycle-substituted purine and 7-deazapurine compounds Grant 9,394,310 - Olhava , et al. July 19, 2 | 2016-07-19 |
Inhibitors of human EZH2, and methods of use thereof Grant 9,333,217 - Copeland , et al. May 10, 2 | 2016-05-10 |
1,4-pyridone Bicyclic Heteroaryl Compounds App 20150344459 - KUNTZ; KEVIN W. ;   et al. | 2015-12-03 |
1,4-pyridone Compounds App 20150344427 - KUNTZ; KEVIN W. ;   et al. | 2015-12-03 |
7-deazapurine modulators of histone methyltransferase, and methods of use thereof Grant 9,145,438 - Chesworth , et al. September 29, 2 | 2015-09-29 |
Method Of Treating Leukemia App 20150216890 - Olhava; Edward J. ;   et al. | 2015-08-06 |
Substituted purine and 7-deazapurine compounds Grant 9,096,634 - Olhava , et al. August 4, 2 | 2015-08-04 |
Inhibitors of Human EZH2, and Methods of Use Thereof App 20150141362 - Copeland; Robert A. ;   et al. | 2015-05-21 |
Modulators of histone methyltransferase, and methods of use thereof Grant 9,029,343 - Chesworth , et al. May 12, 2 | 2015-05-12 |
Inhibitors of human EZH2 and methods of use thereof Grant 8,895,245 - Copeland , et al. November 25, 2 | 2014-11-25 |
Inhibitors of human EZH2 and methods of use thereof Grant 8,691,507 - Copeland , et al. April 8, 2 | 2014-04-08 |
Substituted Purine and 7-Deazapurine Compounds App 20140051654 - Olhava; Edward J. ;   et al. | 2014-02-20 |
Carbocycle-Substituted Purine And 7-Deazapurine Compounds App 20130338173 - Olhava; Edward J. ;   et al. | 2013-12-19 |
Inhibitors of Human EZH2 and Methods of Use Thereof App 20130303555 - Copeland; Robert A. ;   et al. | 2013-11-14 |
Aryl- or heteroaryl-substituted benzene compounds Grant 8,410,088 - Kuntz , et al. April 2, 2 | 2013-04-02 |
Inhibitors of Human EZH2, and Methods of Use Thereof App 20130040906 - Kuntz; Kevin W. ;   et al. | 2013-02-14 |
Aryl- or Heteroaryl-Substituted Benzene Compounds App 20120264734 - KUNTZ; KEVIN W. ;   et al. | 2012-10-18 |
Substituted Purine And 7-Deazapurine Compounds App 20120142625 - Olhava; Edward J. ;   et al. | 2012-06-07 |
Inhibitors of Human EZH2 and Methods of Use Thereof App 20120071418 - Copeland; Robert A. ;   et al. | 2012-03-22 |
Benzimidazol-1-YL-thiophene compounds for the treatment of cancer App 20080269298 - Andrews; Clarence W. ;   et al. | 2008-10-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.